13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060792
Total Value
$391.0M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ENLIVEN THERAPEUTICS INC | ELVN | 5,798,475 | $127.0M | 32.47% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,408,379 | $63.9M | 16.35% |
| 3 | VOR BIOPHARMA INC | VOR | 6,361,723 | $34.2M | 8.75% |
| 4 | RALLYBIO CORP | RLYB | 3,630,724 | $20.7M | 5.30% |
| 5 | CRINETICS PHARMACEUTICALS IN | CRNX | 862,286 | $13.8M | 3.54% |
| 6 | DISC MEDICINE INC | IRON | 588,442 | $12.5M | 3.19% |
| 7 | IDEAYA BIOSCIENCES INC | IDYA | 868,520 | $11.9M | 3.05% |
| 8 | SCPHARMACEUTICALS INC | 810648105 | 1,200,647 | $10.9M | 2.78% |
| 9 | FIBROGEN INC | 31572Q808 | 579,434 | $10.8M | 2.77% |
| 10 | AVIDITY BIOSCIENCES INC | 05370A108 | 665,555 | $10.2M | 2.61% |
| 11 | ARVINAS INC | ARVN | 320,000 | $8.7M | 2.24% |
| 12 | COGENT BIOSCIENCES INC | COGT | 790,440 | $8.5M | 2.18% |
| 13 | ANAPTYSBIO INC | ANABV | 357,733 | $7.8M | 1.99% |
| 14 | VIRIDIAN THERAPEUTICS INC | VRDN | 280,000 | $7.1M | 1.82% |
| 15 | IVERIC BIO INC | 46583P102 | 284,626 | $6.9M | 1.77% |
| 16 | VIKING THERAPEUTICS INC | VKTX | 350,000 | $5.8M | 1.49% |
| 17 | SPRUCE BIOSCIENCES INC | SPRB | 2,364,000 | $5.2M | 1.34% |
| 18 | MERSANA THERAPEUTICS INC | 59045L106 | 1,185,000 | $4.9M | 1.25% |
| 19 | PHARVARIS N V | PHVS | 587,600 | $4.7M | 1.21% |
| 20 | HOMOLOGY MEDICINES INC | 438083107 | 4,535,919 | $4.7M | 1.19% |
| 21 | PEAR THERAPEUTICS INC | 704723105 | 16,744,113 | $4.3M | 1.09% |
| 22 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,884,791 | $4.0M | 1.03% |
| 23 | CIDARA THERAPEUTICS INC | 171757107 | 1,134,511 | $1.4M | 0.37% |
| 24 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 38,856 | $831,130 | 0.21% |